HOME >> MEDICINE >> NEWS
New generation of smallpox vaccines to be tested at Saint Louis University

ST. LOUIS - Two new investigational smallpox vaccines will be studied as part of a clinical trial starting soon at Saint Louis University's Center for Vaccine Development. Saint Louis University is the only location in the United States participating in the trial.

The investigational vaccines, manufactured by Massachusetts-based Acambis Inc., will be compared with the existing smallpox vaccine, known as Dryvax. The new vaccines were produced using modern methods of cell cultivation. Dryvax, the same smallpox vaccine that was provided to all U.S. residents during the period of routine smallpox vaccination, hasn't been produced in many years.

"Although there has not been a case of smallpox in the United States since 1949, the U.S. government has determined that it is necessary to keep smallpox vaccine available, in case the disease is reintroduced through bioterrorism," said Sharon Frey, M.D., principal investigator for the study and associate professor of internal medicine in the division of infectious diseases at Saint Louis University School of Medicine. "A study starting this fall at Saint Louis University is being done to determine the effectiveness of two new investigational smallpox vaccines in healthy adults."

The study will include 90 adult volunteers: 30 receive one newly produced smallpox vaccine, 30 receive the other new vaccine and 30 will receive Dryvax. Like the two newly manufactured vaccines, Dryvax is also considered investigational because researchers will use a different "diluent" to change the vaccine from its dry state (how it's stored) to its liquid state (how it's administered).

"The effectiveness of these smallpox vaccines will be measured by observing whether or not a 'pock,' which resembles a blister, forms at the site of the vaccination, and through blood tests," Frey said. The pock is a typical response to smallpox vaccination and leaves a small scar or depression on the skin at the site of vaccination.
'"/>

Contact: Joe Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
19-Aug-2003


Page: 1 2

Related medicine news :

1. New generation contact lenses cut risk of severe eye infection
2. Genetics important in age-related macular degeneration
3. Gene for age-related macular degeneration discovered by Yale researchers
4. UCSD-Utah team develops mouse model to test therapies for macular degeneration
5. Next generation body scanner launched by the University of Manchester
6. Penn study shows how next-generation diabetic drugs could work more selectively
7. Get ready for next generation surround sound
8. Macular degeneration patients benefit from self-management training
9. New programme will train the next generation of health leaders
10. Pegaptanib provides benefit for neovascular age-related macular degeneration
11. New clue to nerve growth may help regeneration efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
Breaking Medicine Technology:
Cached News: